These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 20440256

  • 1. Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
    Anselmino M, Moretti C, Ravera L, Sheiban I.
    Minerva Cardioangiol; 2010 Apr; 58(2):277-80. PubMed ID: 20440256
    [Abstract] [Full Text] [Related]

  • 2. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.
    Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST.
    Hong Kong Med J; 2005 Oct; 11(5):414-6. PubMed ID: 16219965
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.
    Goyal RK, Srivastava D, Lessnau KD.
    Pharmacotherapy; 2009 May; 29(5):608-12. PubMed ID: 19397467
    [Abstract] [Full Text] [Related]

  • 5. Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
    Lansky AJ, Tsuchiya Y, Brener M, Mehran R, Cristea E, Pietras C, Grines CL, Cox DA, Garcia E, Tcheng JE, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Leon MB, Moses J, Stone GW.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):917-24. PubMed ID: 19016469
    [Abstract] [Full Text] [Related]

  • 6. Acute hepatitis associated with clopidogrel: a case report and review of the literature.
    Pisapia R, Abdeddaim A, Mariano A, Rianda A, Vincenzi L, Taibi C, Baiocchini A, Del Nonno F, DʼOffizi G.
    Am J Ther; 2015 Dec 01; 22(1):e8-e13. PubMed ID: 23846525
    [Abstract] [Full Text] [Related]

  • 7. Clopidogrel-induced hepatotoxicity.
    Wiper A, Schmitt M, Roberts DH.
    J Postgrad Med; 2008 Dec 01; 54(2):152. PubMed ID: 18480537
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues.
    Khambekar SK, Kovac J, Gershlick AH.
    Heart; 2004 Mar 01; 90(3):e14. PubMed ID: 14966075
    [Abstract] [Full Text] [Related]

  • 10. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K, Wilensky RL, Julien MB, Herrmann HC, Spinler SA.
    Ann Pharmacother; 2006 Jun 01; 40(6):1204-7. PubMed ID: 16684808
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 01; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 13. Ticlopidine-induced hepatitis.
    Chen LK, Hsieh BH, Chen WC, Tsai ST, Hou MC.
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan 01; 64(1):59-63. PubMed ID: 11310373
    [Abstract] [Full Text] [Related]

  • 14. [Cholestasic toxic hepatitis due to clopidogrel in a patient with multiple conditions].
    Etxeberria-Lekuona D, Méndez-López I, Mercado MR, Oteiza J, Arteaga M, Jarne V.
    An Sist Sanit Navar; 2016 Apr 29; 39(1):143-8. PubMed ID: 27125614
    [Abstract] [Full Text] [Related]

  • 15. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL, Aronow HD, Cura FA, Bhatt DL, Albirini A, Schneider JP, Topol EJ, Ellis SG.
    Can J Cardiol; 2003 Aug 29; 19(9):1041-6. PubMed ID: 12915931
    [Abstract] [Full Text] [Related]

  • 16. Clopidogrel and ticlopidine cross-reactivity-induced erythroderma following drug-eluting stenting.
    Ziakas A, Theofilogiannakos EK, Daniilidis M, Sotiriadis D, Parisiadou A, Kotsaftis P, Gemitzis K, Parharidis G.
    Cutis; 2013 Dec 29; 92(6):E16-7. PubMed ID: 24416752
    [No Abstract] [Full Text] [Related]

  • 17. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T, Frere C, Quilici J, Morange PE, Mouret JP, Bali L, Moro PJ, Lambert M, Alessi MC, Bonnet JL.
    JACC Cardiovasc Interv; 2008 Dec 29; 1(6):649-53. PubMed ID: 19463379
    [Abstract] [Full Text] [Related]

  • 18. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.
    Thromb Haemost; 2010 Dec 29; 104(6):1211-8. PubMed ID: 20941464
    [Abstract] [Full Text] [Related]

  • 19. Use of prasugrel in a patient with clopidogrel hypersensitivity.
    Peppard SR, Held-Godgluck BM, Beddingfield R.
    Ann Pharmacother; 2011 Oct 29; 45(10):e54. PubMed ID: 21896923
    [Abstract] [Full Text] [Related]

  • 20. Intracranial bleeding associated with clopidogrel.
    Cay S, Yilmaz MB, Korkmaz S.
    Cardiovasc Drugs Ther; 2005 Mar 29; 19(2):157-8. PubMed ID: 16025236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.